The N-of-1 Clinical Trial: A Timely Research Opportunity in HomeopathyFunding The study was supported by grants from the Swiss Homeopathy Association and the PanMedion Foundation, Switzerland.
03 May 2017
11 December 2017
23 January 2018 (eFirst)
Background The randomised controlled trial (RCT) is considered the ‘gold standard’ for establishing treatment efficacy or effectiveness of an intervention, but its data do not infer response in an individual patient. Individualised clinical care, a fundamental principle in complementary and alternative medicine (CAM), including homeopathy, seems well disposed in principle to being researched by single-patient (N-of-1) study design. Guidelines for reporting N-of-1 trials have recently been developed.
Objective To overview the current status in the literature of the N-of-1 method and its application in medicine, including CAM. To consider whether the N-of-1 trial design offers an opportunity for novel research in homeopathy.
N-of-1 Trial Design The N-of-1 trial applies the principles of the conventional crossover, blinded, RCT design. The treatment under study and the comparator are repeated in a randomised order, and with suitable washout time, over a defined period. N-of-1 design is constrained for use in chronic stable conditions, and for interventions that have quick onset and cessation of effect, with modest or negligible carryover. Outcome data can be aggregated and interpreted for the individual subject; they can also be pooled with data from several similar N-of-1 trials, enabling more generalisable conclusions.
The N-of-1 Trial in CAM The typical individualisation of patient care can be accommodated in N-of-1 study design if the patient and the specific therapeutic intervention are selected within the constraints of the method. Application of the N-of-1 method in CAM has been advocated but has been mainly limited, in practice, to a small number of studies in herbal and traditional Chinese medicine.
The N-of-1 Trial in Homeopathy Individualised homeopathy can be accommodated for investigation within the same methodological constraints; less in-depth homeopathic approaches to prescribing are also amendable to investigation using the N-of-1 method. No such studies have been published. We identify three main targets in its ready applicability to homeopathy: (1) to optimise clinical care in an individual patient; (2) to investigate whether the outcomes of treatment using homeopathy differ from those of placebo; (3) to aggregate data from a series of N-of-1 trials to enable broader conclusions about a group of patients or intervention.
Conclusion The N-of-1 trial design offers important new investigative possibilities in homeopathy and should be explored as a means to optimise individualised health care or investigate effectiveness of the homeopathic intervention compared with placebo in individual subjects.
Keywordscomplementary and alternative medicine - homeopathy - N-of-1 trial - single-patient trial - research methods
S.U.Z. and R.T.M. co-developed the original concept. S.U.Z. devised the manuscript and led its writing. Each author has provided edited content and has approved the final manuscript.
- 1 Kleijnen J, Knipschild P, ter Riet G. Clinical trials of homoeopathy. BMJ 1991; 302: 316-323
- 2 Linde K, Clausius N, Ramirez G. , et al. Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet 1997; 350: 834-843
- 3 Linde K, Scholz M, Ramirez G, Clausius N, Melchart D, Jonas WB. Impact of study quality on outcome in placebo-controlled trials of homeopathy. J Clin Epidemiol 1999; 52: 631-636
- 4 Cucherat M, Haugh MC, Gooch M, Boissel JP. ; Homeopathic Medicines Research Advisory Group. Evidence of clinical efficacy of homeopathy. A meta-analysis of clinical trials. Eur J Clin Pharmacol 2000; 56: 27-33
- 5 Shang A, Huwiler-Müntener K, Nartey L. , et al. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet 2005; 366: 726-732
- 6 Kravitz RL, Duan N, Vohra S, Li J. ; the DEcIDE Methods Center N-of-1 Guidance Panel. Introduction to N-of-1 trials: indications and barriers. In: Kravitz RL, Duan N. , eds. Design and Implementation of N-of-1 Trials: A User's Guide. AHRQ Publication No. 13(14)-EHC122-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2014: 1-12
- 7 Guyatt G, Zhang Y, Jaeschke R, McGinn T. N-of-1 randomized clinical trials. In: Guyatt G, Rennie D, Meade MO, Cook DJ. , eds. User's Guide to the Medical Literature: A Manual for Evidence-Based Clinical Practice. 3rd ed. Chicago: McGraw-Hill Professional; 2015: 151-161
- 8 Guyatt G, Sackett D, Adachi J. , et al. A clinician's guide for conducting randomized trials in individual patients. CMAJ 1988; 139: 497-503
- 9 Vohra S, Shamseer L, Sampson M. , et al; CENT Group. CONSORT extension for reporting N-of-1 trials (CENT) 2015 statement. BMJ 2015; 350: h1738
- 10 Nikles J. What are N-of-1 trials?. In: Nikles J, Mitchell G. , eds. The Essential Guide to N-of-1 Trials in Health. Heidelberg: Springer; 2015: 9-18
- 11 Tate RL, McDonald S, Perdices M, Togher L, Schultz R, Savage S. Rating the methodological quality of single-subject designs and n-of-1 trials: introducing the Single-Case Experimental Design (SCED) Scale. Neuropsychol Rehabil 2008; 18: 385-401
- 12 Tate RL, Perdices M, Rosenkoetter U. , et al. Revision of a method quality rating scale for single-case experimental designs and n-of-1 trials: the 15-item risk of bias in N-of-1 Trials (RoBiNT) Scale. Neuropsychol Rehabil 2013; 23: 619-638
- 13 Carriere KC, Li Y, Mitchell G, Senior H. Methodological considerations of N-of-1 trials. In: Nikles J, Mitchell G. , eds. The Essential Guide to N-of-1 Trials in Health. Heidelberg: Springer; 2015: 67-80
- 14 Senior H. Randomization, allocation concealment, and blinding. In: Nikles J, Mitchell G. , eds. The Essential Guide to N-of-1 Trials in Health. Heidelberg: Springer; 2015: 81-92
- 15 Guyatt G, Sackett D, Taylor DW, Chong J, Roberts R, Pugsley S. Determining optimal therapy--randomized trials in individual patients. N Engl J Med 1986; 314: 889-892
- 16 Larson EB. N-of-1 clinical trials. A technique for improving medical therapeutics. West J Med 1990; 152: 52-56
- 17 Kravitz RL, Duan N, Niedzinski EJ, Hay MC, Subramanian SK, Weisner TS. What ever happened to N-of-1 trials? Insiders' perspectives and a look to the future. Milbank Q 2008; 86: 533-555
- 18 Lillie EO, Patay B, Diamant J, Issell B, Topol EJ, Schork NJ. The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?. Per Med 2011; 8: 161-173
- 19 Kravitz RL, Duan N. , eds. Design and Implementation of N-of-1 Trials: A User's Guide. AHRQ Publication No. 13(14)-EHC122-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2014
- 20 Nikles J, Mitchell G. , eds. The Essential Guide to N-of-1 Trials in Health. Heidelberg: Springer; 2015
- 21 Shamseer L, Sampson M, Bukutu C. , et al; CENT Group. CONSORT extension for reporting N-of-1 trials (CENT) 2015: explanation and elaboration. BMJ 2015; 350: h1793
- 22 Gabler NB, Duan N, Vohra S, Kravitz RL. N-of-1 trials in the medical literature: a systematic review. Med Care 2011; 49: 761-768
- 23 Punja S, Bukutu C, Shamseer L. , et al. Systematic review of the methods, statistical analysis and meta-analysis of N-of-1 trials. In: Punja S. , ed. N-of-1 Methods and their Contribution to Systematic Reviews and Meta-Analyses [thesis]. University of Alberta; 2014: 13-47
- 24 Shaffer JA, Falzon L, Cheung K, Davidson KW. N-of-1 randomized trials for psychological and health behavior outcomes: a systematic review protocol. Syst Rev 2015; 4: 87
- 25 Li J, Gao W, Punja S. , et al. Reporting quality of N-of-1 trials published between 1985 and 2013: a systematic review. J Clin Epidemiol 2016; 76: 57-64
- 26 Nikles J. Where are N-of-1 trials headed?. In: Nikles J, Mitchell G. , eds. The Essential Guide to N-of-1 Trials in Health. Heidelberg: Springer; 2015: 233-242
- 27 Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Clin Epidemiol 2009; 62: 499-505
- 28 International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Choice of Control Group in Clinical Trials 2000. Available at: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E10/Step4/E10_Guideline.pdf . Accessed December 3, 2016
- 29 International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Statistical Principles for Clinical Trials 1998. Available at: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E9/Step4/E9_Guideline.pdf . Accessed December 3, 2016
- 30 Schulz KF, Altman DG, Moher D. ; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Int J Surg 2011; 9: 672-677
- 31 Guyatt G, Jaeschke R, Wilson MC, Montori VM, Richardson WS. What is evidence-based medicine?. In: Guyatt G, Rennie D, Meade MO, Cook DJ. , eds. User's Guide to the Medical Literature: A Manual for Evidence-Based Clinical Practice. 3rd ed. Chicago: McGraw-Hill Professional; 2015: 7-14
- 32 Punja S, Schmid CH, Hartling L, Urichuk L, Nikles CJ, Vohra S. Amphetamine and methylphenidate for pediatric ADHD: a combined meta-analysis of N-of-1 trial data with RCT data. In: Punja S. , ed. N-of-1 Methods and Their Contribution to Systematic Reviews and Meta-Analyses [thesis]. University of Alberta; 2014: 197-212
- 33 Punja S. N-of-1 Methods and Their Contribution to Systematic Reviews and Meta-Analyses [thesis]. University of Alberta; 2014
- 34 Duan N, Kravitz RL, Schmid CH. Single-patient (n-of-1) trials: a pragmatic clinical decision methodology for patient-centered comparative effectiveness research. J Clin Epidemiol 2013; 66: S21-S28
- 35 Schmid CH, Duan N. The DEcIDE Methods Center N-of-1 Guidance Panel. Statistical design and analytic considerations for N-of-1 trials. In: Kravitz RL, Duan N. , eds. Design and Implementation of N-of-1 Trials: A User's Guide. AHRQ Publication No. 13(14)-EHC122-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2014: 33-54
- 36 Mitchell G. Aggregated N-of-1 trials. In: Nikles J, Mitchell G. , eds. The Essential Guide to N-of-1 Trials in Health. Heidelberg: Springer; 2015: 57-66
- 37 Zucker DR, Schmid CH, McIntosh MW, D'Agostino RB, Selker HP, Lau J. Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment. J Clin Epidemiol 1997; 50: 401-410
- 38 Zucker DR, Ruthazer R, Schmid CH. Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerations. J Clin Epidemiol 2010; 63: 1312-1323
- 39 Nikles J, Mitchell GK, Schluter P. , et al. Aggregating single patient (n-of-1) trials in populations where recruitment and retention was difficult: the case of palliative care. J Clin Epidemiol 2011; 64: 471-480
- 40 Senior H. Data collection and quality control. In: Nikles J, Mitchell G. , eds. The Essential Guide to N-of-1 Trials in Health. Heidelberg: Springer; 2015: 93-104
- 41 Senior H. Assessing and reporting adverse events. In: Nikles J, Mitchell G. , eds. The Essential Guide to N-of-1 Trials in Health. Heidelberg: Springer; 2015: 115-124
- 42 Whitty JA, Byrnes JM, Scuffham PA. The economics of N-of-1 trials. In: Nikles J, Mitchell G. , eds. The Essential Guide to N-of-1 Trials in Health. Heidelberg: Springer; 2015: 155-174
- 43 Punja S, Vohra S, Eslick I, Duan N. ; the DEcIDE Methods Center N-of-1 Guidance Panel. An ethical framework for N-of-1 trials: Clinical care, quality improvement, or human subjects research?. In: Kravitz RL, Duan N. , eds. Design and Implementation of N-of-1 Trials: A User's Guide. AHRQ Publication No. 13(14)-EHC122-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2014: 13-22
- 44 Crowden A, Guyatt G, Stepanov N, Vohra S. Research ethics and N-of-1 trials. In: Nikles J, Mitchell G. , eds. The Essential Guide to N-of-1 Trials in Health. Heidelberg: Springer; 2015: 125-134
- 45 International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Guideline for Good Clinical Practice 1996. Available at: http://www.ich.org/products/guidelines/efficacy/efficacy-single/article/good-clinical-practice.html . Accessed July 12, 2016
- 46 Gaus W, Högel J. Studies on the efficacy of unconventional therapies. Problems and designs. Arzneimittelforschung 1995; 45: 88-92
- 47 Hart A, Sutton CJ. n-of-1 trials and their combination: suitable approaches for CAM research?. Complement Ther Med 2003; 11: 213-214
- 48 Johnston BC, Mills E. N-of-1 randomized controlled trials: an opportunity for complementary and alternative medicine evaluation. J Altern Complement Med 2004; 10: 979-984
- 49 Sung L, Feldman BM. N-of-1 trials: innovative methods to evaluate complementary and alternative medicines in pediatric cancer. J Pediatr Hematol Oncol 2006; 28: 263-266
- 50 Goldenberg JZ, Wenner CA. A novel N of 1 trial design and proposed utility in complementary and alternative medicine research. J Evid Based Complementary Altern Med 2012; 17: 126-130
- 51 Nahin RL, Straus SE. Research into complementary and alternative medicine: problems and potential. BMJ 2001; 322: 161-164
- 52 Coxeter PD, Schluter PJ, Eastwood HL, Nikles CJ, Glasziou PP. Valerian does not appear to reduce symptoms for patients with chronic insomnia in general practice using a series of randomised n-of-1 trials. Complement Ther Med 2003; 11: 215-222
- 53 Jackson A, MacPherson H, Hahn S. Acupuncture for tinnitus: a series of six n=1 controlled trials. Complement Ther Med 2006; 14: 39-46
- 54 Lee S, Lim N, Choi SM, Kim S. Validation study of Kim's sham needle by measuring facial temperature: an N-of-1 randomized double-blind placebo-controlled clinical trial. Evid Based Complement Alternat Med 2012; DOI: 10.1155/2012/507937.
- 55 Yuhong H, Qian L, Yu L. , et al. An N-of-1 trial service in clinical practice: testing the effectiveness of Liuwei Dihuang decoction for kidney-Yin deficiency syndrome. Evid Based Complement Alternat Med 2013; DOI: 10.1155/2013/827915.
- 56 Huang H, Yang P, Xue J. , et al. Evaluating the individualized treatment of traditional Chinese medicine: a pilot study of N-of-1 trials. Evid Based Complement Alternat Med 2014; DOI: 10.1155/2014/148730.
- 57 Li J, Tian J, Ma B, Yang K. N-of-1 trials in China. Complement Ther Med 2013; 21: 190-194
- 58 Kawakita K, Suzuki M, Namura K, Tanzawa S. A proposal for a simple and useful research design for evaluating the efficacy of acupuncture: multiple, randomized n-of-1 trials. Japanese Acupuncture and Moxibustion 2005; 1: 9-15
- 59 Kawakita K, Shichidou T, Inoue E. , et al. Do Japanese style acupuncture and moxibustion reduce symptoms of the common cold?. Evid Based Complement Alternat Med 2008; 5: 481-489
- 60 Witt C, Linde K. Clinical Research in Complementary and Integrative Medicine: A Practical Training Book. Munich: Urban & Fischer Verlag/Elsevier GmbH; 2011
- 61 Teut M, Linde K. Scientific case research in complementary and alternative medicine–a review. Complement Ther Med 2013; 21: 388-395
- 62 Dahler J. Potenzen und ihre k Dosierung. In: Teut M, Dahler J, Lucae C. , et al, eds. Kursbuch Homöopathie. 2nd ed. München: Urban & Fischer Verlag/Elsevier GmbH; 2016: 135-148
- 63 Hahnemann S. Organon der Heilkunst. Originalgetreuer Nachdruck der sechsten Auflage von 1921. Kandern, Germany: Narayana-Verlag; 2011
- 64 Ludtke R, Wiesenauer M. A meta-analysis of the homeopathic treatment of pollinosis with Galphimia glauca. Forsch Komplementarmed 1996; 3: 230-236
- 65 Cooper KL, Relton C. Homeopathy for insomnia: a systematic review of research evidence. Sleep Med Rev 2010; 14: 329-337
- 66 Ernst E. Homeopathy for insomnia and sleep-related disorders: a systematic review of randomised controlled trials. Focus Altern Complement Ther 2011; 16: 195-199
- 67 Long L, Ernst E. Homeopathic remedies for the treatment of osteoarthritis: a systematic review. Br Homeopath J 2001; 90: 37-43
- 68 Taylor MA, Reilly D, Llewellyn-Jones RH, McSharry C, Aitchison TC. Randomised controlled trial of homoeopathy versus placebo in perennial allergic rhinitis with overview of four trial series. BMJ 2000; 321: 471-476
- 69 Ernst E. Homeopathic Galphimia glauca for hay fever: a systematic review of randomised clinical trials and a critique of a published meta-analysis. Focus Altern Complement Ther 2011; 16: 200-203
- 70 Ernst E. Homeopathic prophylaxis of headaches and migraine? A systematic review. J Pain Symptom Manage 1999; 18: 353-357
- 71 Yakir M, Kreitler S, Brzezinski A, Vithoulkas G, Oberbaum M, Bentwich Z. Effects of homeopathic treatment in women with premenstrual syndrome: a pilot study. Br Homeopath J 2001; 90: 148-153
- 72 Mathie RT, Lloyd SM, Legg LA. , et al. Randomised placebo-controlled trials of individualised homeopathic treatment: systematic review and meta-analysis. Syst Rev 2014; 3: 142
- 73 Katz T, Fisher P, Katz A, Davidson J, Feder G. The feasibility of a randomised, placebo-controlled clinical trial of homeopathic treatment of depression in general practice. Homeopathy 2005; 94: 145-152
- 74 Adler UC, Krüger S, Teut M. , et al. Homeopathy for depression: a randomized, partially double-blind, placebo-controlled, four-armed study (DEP-HOM). PLoS One 2013; 8: e74537
- 75 Bell IR. Depression research in homeopathy: hopeless or hopeful?. Homeopathy 2005; 94: 141-144